Skip to main content
Publications
Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, Barlesi F, Price M , Chirila C , Hollis K , Sweeney C , Wolowacz S , Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study . Lung Cancer. 2018 Oct;124:310-6. doi: 10.1016/j.lungcan.2018.07.042.
Coates L, Gossec L, Kirkham B, Sherif B , Gaillez C, Mpofu S, Jugl SM, Karyekar C, Gandhi KK. Minimal disease activity among active psoriatic arthritis patients treated with Secukinumab: 2-year results from a multicenter, randomized, double-blind, parallel-group, placebo-controlled phase III study . Arthritis Care Res (Hoboken). 2018 Oct;70(10):1529-35. doi: 10.1002/acr.23537
Jia X, Zhao Y, Carrico J, Brodtkorb TH , Mendelsohn A, Lowry S, Feldman S, Wu JJ, Armstrong A. Cost-effectiveness analysis of tildrakizumab in patients with moderate to severe plaque psoriasis in the United States . Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):S78.
Jia X, Zhao Y, Carrico J, Brodtkorb TH , Mendelsohn A, Lowry S, Feldman S, Armstrong A, Wu JJ. Comparative cost per time in response for tildrakizumab and other targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis in the United States . Poster presented at the 2018 AMCP NEXUS; October 22, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10a):S79.
Margulis AV , Linder M, Arana A , Pottegard A, Berglind IA, Bui CL , Kristiansen NS, Bahmanyar S, McQuay LJ, Atsma WJ, Appenteng K, D'Silva M, Perez-Gutthann S , Hallas J. Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom . PLoS One. 2018 Sep 27;13(9):e0204456. doi: 10.1371/journal.pone.0204456
Saif W, Parikh R , Ray D, Kaye JA, Kurosky S, Thomas S, Halfdanarson T, Beveridge T, Mirakhur B, Lubeck CA, Nagar SP , Soares H. The sequencing of lanreotide (LAN) after octreotide LAR (OCT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) . Poster presented at the NANETS Regional NET Education Conference; September 15, 2018. New Brunswick, NJ. Previously presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Carsin A , Fuertes E, Jarvis D, Anto JM, Heinrich J, Bono R, Svanes C, Schaffner E, Emtner M, Dharmage S, Raza W, Leynaert B, Pascual S, Probst N, Garcia-Aymerich J. A restrictive spirometry pattern is associated with lower physical activity levels in adults . Poster presented at the 2018 European Respiratory Society (ERS) Congress; September 18, 2018. Paris, France. [abstract] Eur Respir J. 2018 Sep 15; 52(Suppl 62):1576. doi: 10.1183/1393003.congress-2017.PA1576
Ramon MA, Ter Riet G, Carsin AE , Gimeno-Santos E, Agusti A, Anto JM, Donaire-Gonzalez D, Ferrer J, Rodriguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J, PAC-COPD Study Group. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model . Eur Respir J. 2018 Sep 15;52(3):1800079. doi: 10.1183/13993003.00079-2018
Mytelka DS, Nagar SP , D'yachkova Y, La EM, Kaye JA, Candrilli SD , Kasper B, Lopez-Martin JA, Lorenzo M. Health care resource utilization and costs among adult patients with advanced soft tissue sarcoma: a retrospective medical record review in the United Kingdom, Spain, Germany, and France . Sarcoma. 2018 Sep 12;2018:2020591. doi: 10.1155/2018/2020591
Robertson G, Peto T, van Beek E, Fleming A , van Hemert J, Williams MC, Trucco E, Quinn N, Hogg R, McKay G, Pellegrini E, Newby DE, Dillon B, Kee F, Young I, MacGillivray T. Classification of hypertension using nasal annular arteriole-venule ratio in ultra-widefield ophthalmic imaging . Poster presented at the Joint Hypertension 2018 Scientific Sessions; September 6, 2018. Chicago, United Kingdom.
Mease P, Gladman D, Davenport E , Zhou X , Guerette B, Teng L, Kaura S, Nash P. Improvements in work productivity with up to 104 weeks of apremilast monotherapy: results from a phase 3b, randomized, controlled study in biologic-naïve subjects with active psoriatic arthritis . Poster presented at the 37th Scandinavian Congress of Rheumatology; September 5, 2018. Helsinki, Finland. [abstract] Scand J Rheumatol. 2018 Sep 5; 47(Suppl 129):34-5. Previously presented at the 2017 ACR/ARHP Annual Meeting.
Margulis AV , Fortuny J , Kaye JA, Calingaert B , Reynolds M , Plana E , McQuy LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S , Arana A . Value of free-text comments for validating cancer cases using primary-care data in the United Kingdom . Epidemiology. 2018 Sep;29(5):e41-2.
Castellsague J, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Calingaert B , Bui C , Arana A , Laguna C, Gonzalez-Rubio F, Roso-Llorach A, Prados-Torres A, Perez-Gutthann S . Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany . Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):953-61. doi: 10.1002/pds.4584